In the FD: 'Woundcare company Plasmacure receives €16m capital injection'

Plasmacure 

The Nijmegen-based woundcare company received €16m investment in a round led by US-based distributor Venture Medical, OostNL, VGZ, Triade and Noaber was highlighted in Het Financieele Dagblad. The article a.o. demonstrates Plasmacure’s technological principle, future path for growth and what sets Plasoma apart as highlighted by Peter Haasjes:

“Its portability and suitability for home use.” In addition, the device operates using regular air, without the need for added noble gases. “That’s a competitive advantage — and Venture Medical recognizes it as such as well.”

Read the full article here.